2026 CS Plenary Sessions
Chronic Hand Eczema: Burden and Treatments
Dr. JiaDe Yu presented information about the burden, pathogenesis, diagnosis, and treatment of chronic hand eczema (CHE). CHE is hand eczema that lasts >3 months or relapses >2 times per year. It is considered a subtype of atopic dermatitis (AD) or contact dermatitis (CD) in the United States and a stand-alone diagnosis in Europe. Yu…
Photoprotection in Skin of Color: Understanding Photodamage and Optimizing Sunscreen Strategies
Dr. Susan Taylor presented information about personalized photoprotection strategies for individuals with skin of color. Photoprotection is the process of preventing the deleterious effects of the electromagnetic radiation (EMR) spectrum, including ultraviolet radiation (UVR), visible light (VL), and infrared light on the skin. It is necessary to maintain skin health and prevent photodamage, photoaging, and…
Updates in Pediatric Allergic Contact Dermatitis: What’s Hot and What’s Not
Dr. JiaDe Yu presented information about pediatric allergic contact dermatitis (ACD). ACD is a skin rash caused by direct contact with an allergen. First, Yu discussed the prevalence of pediatric ACD. An estimated one-third of children will develop ACD; it may be overlooked because atopic dermatitis (AD) may have a similar appearance and is highly…
Mimickers of SJS/TEN
Dr. Jean Bolognia presented information about Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and diseases that mimic them. SJS and TEN are severe skin reactions that cause damage to the skin and mucus membranes and can be life-threatening. TEN typically involves the entire trunk. First, Bolognia discussed the expanding differential diagnosis of SJS/TEN. Previously, dermatologists would…
Antibody-Drug Conjugates (Chemo-labeled Antibodies)
Dr. Jean Bolognia presented information about antibody-drug conjugates (ADCs), including enfortumab vedotin, trastuzumab emtansine, trastuzumab deruxtecan, and loncastuximab tesirine. ADCs are monoclonal antibodies (mAbs) combined with a chemotherapeutic agent via a linker. They are associated with cutaneous side effects that dermatologists need to know about. First, Bolognia explained the nomenclature of ADCs. The first part…
Alopecia Areata: An Update
Dr. Susan Taylor presented information about the pathogenesis, clinical features, diagnosis, and treatment of alopecia areata (AA). AA has a significant impact on patient quality of life, including low self-esteem, emotional distress, mood disturbances, and disrupted relationships. Thus, patients need timely diagnosis and appropriate treatment. First, Taylor discussed AA pathogenesis and clinical features. AA pathogenesis…
Update on the Management of Genitourinary Syndrome of Menopause
Dr. Colleen Stockdale presented information that dermatologists should know about genitourinary syndrome of menopause (GSM), including epidemiology, clinical presentation, differential diagnosis, and treatment options. GSM is an umbrella term describing the signs and symptoms of the female genitourinary tract caused by estrogen deficiency; it includes what was formerly called vaginal atrophy and atrophic vaginitis. Dermatologists…
Evaluation of Vulvovaginal Disorders
Dr. Colleen Stockdale presented information about trauma-informed care and its application when evaluating vulvovaginal disorders. First, Stockdale described the principles of trauma-informed care. Trauma may be physical or psychological, including sexual violence, intimate partner violence, adverse childhood experiences, neglect, loss, war and conflict, poverty, community violence, discrimination, medical trauma, and natural disasters. Trauma-informed care is…
Updates in Autoimmune Blistering Disease: Established and Emerging Therapies
Dr. Cory Simpson presented information about the autoimmune blistering diseases pemphigus and pemphigoid, including their pathogenesis, varied clinical presentations, diagnostic work-up, and available and emerging treatment options. First, Simpson described the pathogenesis and clinical presentation of pemphigus and pemphigoid. Both are autoimmune diseases caused by the immune system attacking certain proteins present in the skin…
Defining Novel Druggable Pathways in Darier, Hailey-Hailey, and Grover Disease: From Bedside to Bench and Back
Dr. Cory Simpson presented information about his research identifying novel therapeutic targets for rare skin blistering disorders, including Darier, Hailey-Hailey, and Grover disease. First, Simpson described the clinical features, pathology, and genetics of Darier and Hailey-Hailey disease. Both diseases are autosomal dominant with adolescent onset. They may present with flaccid blisters, crusted erosions, and fissured…